A Novel Suberoylanilide Hydroxamic Acid Histone Deacetylase Inhibitor Derivative, N25, Exhibiting Improved Antitumor Activity in both Human U251 and H460 Cells |
Zhang, Song
(Department of Pharmacology, College of Pharmacy, Guangdong Pharmaceutical University)
Huang, Wei-Bin (Department of Pharmacology, College of Pharmacy, Guangdong Pharmaceutical University) Wu, Li (Department of Pharmacology, College of Pharmacy, Guangdong Pharmaceutical University) Wang, Lai-You (Department of Pharmacology, College of Pharmacy, Guangdong Pharmaceutical University) Ye, Lian-Bao (Department of Pharmacology, College of Pharmacy, Guangdong Pharmaceutical University) Feng, Bing-Hong (Department of Pharmacology, College of Pharmacy, Guangdong Pharmaceutical University) |
1 | Al-Yacoub N, Fecker LF, Mobs M, et al (2012). Apoptosis induction by SAHA in cutaneous T-cell lymphoma cells is related to downregulation of c-FLIP and enhanced TRAIL signaling. J Invest Dermatol, 132, 2263-74. DOI ScienceOn |
2 | Ammerpohl O, Thormeyer D, Khan Z, et al (2004). HDACi phenylbutyrate increases bystander killing of HSV-tk transfected glioma cells. Biochem Biophys Res Commun, 324, 8-14. DOI ScienceOn |
3 | Finnin MS, Donigian JR, Cohen A, et al (1999). Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature, 401, 188-93. DOI ScienceOn |
4 | Ellis L, Pan Y, Smyth GK, et al (2008). Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma. Clin Cancer Res, 14, 4500-10. DOI ScienceOn |
5 | Eymin B, Leduc C, Coll JL, Brambilla E, Gazzeri S (2003). p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice. Oncogene, 22, 1822-35. DOI ScienceOn |
6 | Feng T, Wang H, Su H, et al (2013). Novel N-hydroxyfurylacrylamide-based histone deacetylase (HDAC) inhibitors with branched CAP group (Part 2). Bioorg Med Chem, 21, 5339-54. DOI ScienceOn |
7 | Hoshino I, Matsubara H (2010). Recent advances in histone deacetylase targeted cancer therapy. Surg Today, 40, 809-15. DOI |
8 | Hoshino I, Matsubara H, Akutsu Y, et al (2007). Gene expression profiling induced by histone deacetylase inhibitor, FK228, in human esophageal squamous cancer cells. Oncol Rep, 18, 585-92. |
9 | Hrebackova J, Poljakova J, Eckschlager T, et al (2009). Histone deacetylase inhibitors valproate and trichostatin A are toxic to neuroblastoma cells and modulate cytochrome P450 1A1, 1B1 and 3A4 expression in these cells. Interdiscip Toxicol, 2, 205-10. |
10 | Ito N, Sawa H, Nagane M, et al (2001). Inhibitory effects of sodium butyrate on proliferation and invasiveness of human glioma cells. Neurosurgery, 49, 430-6, 436-7. |
11 | Di Micco S, Terracciano S, Bruno I, et al (2008). Molecular modeling studies toward the structural optimization of new cyclopeptide-based HDAC inhibitors modeled on the natural product FR235222. Bioorg Med Chem, 16, 8635-42. DOI ScienceOn |
12 | Darvas K, Rosenberger S, Brenner D, et al (2010). Histone deacetylase inhibitor-induced sensitization to TNFalpha/TRAIL-mediated apoptosis in cervical carcinoma cells is dependent on HPV oncogene expression. Int J Cancer, 127, 1384-92. DOI ScienceOn |
13 | Di Fiore A, Maresca A, Supuran CT, De Simone G (2012). Hydroxamate represents a versatile zinc binding group for the development of new carbonic anhydrase inhibitors. Chem Commun (Camb), 48, 8838-40. DOI ScienceOn |
14 | Di Micco S, Chini MG, Terracciano S, et al (2013). Structural basis for the design and synthesis of selective HDAC inhibitors. Bioorg Med Chem, 21, 3795-807. DOI ScienceOn |
15 | Dubois F, Caby S, Oger F, et al (2009). Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni. Mol Biochem Parasitol, 168, 7-15. DOI ScienceOn |
16 | Duo J, Ma Y, Wang G, Han X, Zhang C (2013). Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line. DNA Cell Biol, 32, 156-64. DOI ScienceOn |
17 | Li Y, Liu B, Fukudome EY, et al (2011). Identification of citrullinated histone H3 as a potential serum protein biomarker in a lethal model of lipopolysaccharide-induced shock. Surgery, 150, 442-51. DOI ScienceOn |
18 | Takai N, Kira N, Ishii T, et al (2011). Novel chemotherapy using histone deacetylase inhibitors in cervical cancer. Asian Pac J Cancer Prev, 12, 575-80. |
19 | Shinji C, Maeda S, Imai K, et al (2006). Design, synthesis, and evaluation of cyclic amide/imide-bearing hydroxamic acid derivatives as class-selective histone deacetylase (HDAC) inhibitors. Bioorg Med Chem, 14, 7625-51. DOI ScienceOn |
20 | Sriraksa R, Limpaiboon T (2013). Histone deacetylases and their inhibitors as potential therapeutic drugs for cholangiocarcinoma - cell line findings. Asian Pac J Cancer Prev, 14, 2503-8. 과학기술학회마을 DOI ScienceOn |
21 | Kerr JS, Galloway S, Lagrutta A, et al (2010). Nonclinical safety assessment of the histone deacetylase inhibitor vorinostat. Int J Toxicol, 29, 3-19. DOI ScienceOn |
22 | Wanczyk M, Roszczenko K, Marcinkiewicz K, et al (2011). HDACi--going through the mechanisms. Front Biosci (Landmark Ed), 16, 340-59. DOI |
23 | Xia G, Schneider-Stock R, Diestel A, et al (2008). Helicobacter pylori regulates p21 (WAF1) by histone H4 acetylation. Biochem Biophys Res Commun, 369, 526-31. DOI ScienceOn |
24 | Yoshioka T, Yogosawa S, Yamada T, Kitawaki J, Sakai T (2013). Combination of a novel HDAC inhibitor OBP-801/YM753 and a PI3K inhibitor LY294002 synergistically induces apoptosis in human endometrial carcinoma cells due to increase of Bim with accumulation of ROS. Gynecol Oncol, 129, 425-32. DOI ScienceOn |
25 | Li XH, Huang ML, Wang SM, Wang Q (2013). Selective inhibition of bicyclic tetrapeptide histone deacetylase inhibitor on HDAC4 and K562 leukemia cells. Asian Pac J Cancer Prev, 14, 7095-100. 과학기술학회마을 DOI ScienceOn |
26 | Miller CP, Ban K, Dujka ME, et al (2007). NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells. Blood, 110, 267-77. DOI ScienceOn |
27 | Nelson HH, Marsit CJ, Christensen BC, et al (2012). Key epigenetic changes associated with lung cancer development: results from dense methylation array profiling. Epigenetics, 7, 559-66. DOI |
28 | Osada H, Tatematsu Y, Sugito N, Horio Y, Takahashi T (2005). Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines. Mol Carcinog, 44, 233-41. DOI ScienceOn |